The trial is for its peripheral nerve stimulation technique, where electrical leads are implanted in the lower back and mild pulses are sent to interrupt pain signals traveling to the brain, according to the report.
Medtronic is looking to recruit 323 people at 30 centers across the U.S. The study could last up to five years. The company started similar trials in Europe, Israel, Australia and Canada.
More Articles on Devices:
Medical Device Purchase: 3 Statistics on Physician Influence
FDA Increases Stryker Knee Device Recall to Class 1
31 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in March
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
